Value Focused Development
When we are engaged in conversations about developing medicines, how often do you hear language thrown around such as “capturing the value,” “fast to the next value inflection point,” or words to this effect? Drug development is a complex and risky business where remuneration for value creation occurs, by analogy, by passing the baton from … Continued